Triethylene Melamine in the Treatment of Lymphomas and Leukemias
- 1 March 1954
- journal article
- Published by Elsevier in Medical Clinics of North America
- Vol. 38 (2), 541-554
- https://doi.org/10.1016/s0025-7125(16)34896-9
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- DERMATITIS DUE TO TRIETHYLENE MELAMINE THERAPYJAMA, 1953
- Über die Behandlung von Hämoblastosen mit Triäthylenmelamin (TEM)Deutsche Medizinische Wochenschrift (1946), 1953
- Triethylene Melamine in Human Malignant DiseaseBMJ, 1953
- Klinische Erfahrungen mit Triäthylenmelamin (TEM)Deutsche Medizinische Wochenschrift (1946), 1953
- Cytostase Durch Triäthylenmelamin (Tem) Bei Lymphogranulomatose Und Chronischen LeukämienKlinische Wochenschrift, 1952
- Triethylene melamine in clinical cancer chemotherapyAmerican Journal Of Medicine, 1952
- USE OF TRIETHYLENE MELAMINE IN TREATMENT OF LEUKEMIA AND LEUKOSARCOMAPublished by American Medical Association (AMA) ,1952
- FURTHER OBSERVATIONS ON THE USE OF TRIETHYLENE MELAMINE IN NEOPLASTIC DISEASESArchives of Internal Medicine, 1952
- New Cytotoxic Agents with Tumour-Inhibitory ActivityNature, 1950
- The use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinomaCancer, 1948